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Available online 15 January 2016Intrahepatic cholangiocarcinoma (ICC) is the second most common type of malignant primary tumors in the
liver. ICC is an aggressive cancer with a poor survival and limited therapeutic options. At the histological level,
ICC is characterized by an abundant stroma (i.e. the tumor microenvironment that notably includes components
of the extracellular matrix, stromal cells and soluble factors). Tumor microenvironment is known to play a key
role in tumor onset and progression but it is poorly characterized at the molecular level. Thus, this study was
speciﬁcally designed to identify genes that are signiﬁcantly deregulated in the tumor microenvironment of
human ICC. Here we provide a detailed description of the experimental design and methods used to acquire
the genomic data deposited into Gene Expression Omnibus (GEO) under the accession number GSE45001.
Our genomic dataset provides insights on the molecular pathways altered in the microenvironment of ICC and
allows the identiﬁcation of novel ICC biomarkers, as exempliﬁed previously in Hepatology (PMID: 23775819).
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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tocol fulﬁlled national lawsethical committees.
Sample source location Rennes, FranceConsent Written informed consent was obtained from alland regulations and was approved by the local1. Direct link to deposited data
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE45001tabolisms and Cancer, F-35033
arn).
. This is an open access article under2. Experimental design, materials and methods
2.1. General objective and experimental design
The aim of the study was to identify genes signiﬁcantly deregulated
in the microenvironment of human ICC. For this purpose, we applied
a gene expression proﬁling approach using Agilent pangenomic
microarrays and total RNA isolated from human ICC samples after
laser capture microdissection (LCM) of the normal vs. tumoral
microenvironment, as previously reported [1].
2.2. Patients
Gene expression proﬁling was performed from fresh frozen tissues
of 10 patients with ICC [1]. Fresh frozen tissues and formalin-ﬁxed
parafﬁn-embedded (FFPE) tissues were provided by the biobank of
the hospital-university (Centre de Ressources Biologiques [CRB] Santé
de Rennes; BB-0033-00056). Patients underwent liver resection at
Rennes university hospital between Jan. 1997 and Aug. 2011. Only
mass-forming types ICC were included, as deﬁned by the Liver Cancer
Study Group of Japan. Written informed consent was obtained from
all patients. The study protocol fulﬁlled national laws and regulations
and was approved by the local ethics committee and the Institutional
Review Board (IRB00003888) of Inserm (IORG0003254).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Quality control of tissue samples before and after laser capture microdissection (LCM). H&E staining of representative non-tumoral (A) and tumoral (B) ICC samples. (C) From left to
right, LCMof the stroma froma tumoral ICC sample. (D) Tissue sample after LCMhighlightingvarious regionsofmicrodissected stroma thatwere collected on a cap before RNA extraction (E).
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The integrity and the quality of all tissue sectionswere ﬁrst validated
at the histological level after hematoxylin and eosin (H&E) staining byFig. 2.Quality control ofmicroarray images using Feature Extraction algorithm. (A)Histogramo
of variation as a function of signal intensity. (C) Signal intensity of Agilent spike-In RNA feature
large spectrum of RNA abundance.an experienced liver pathologist (Fig. 1A–B). LCM was then performed
to isolate the ﬁbrous tissue from tumoral and non-tumoral ICC samples.
LCM was performed using the Arcturus Veritas™ microdissection
system (Applied Biosystems, Carlsbad, CA). From frozen tissues,f background subtracted signals showing a broad signal distribution (5 Log). (B) Percentage
s as a function of their relative concentration demonstration a linearity of the signal over a
Fig. 4. Principal Component Analysis (PCA) analysis of tumor (blue) and non tumoral
(red) microdissected ICC samples. PCA scores are visually represented in a 3D scatter
plot.
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(Leica Microsystems, Wetzlar, Germany) and mounted onto a PEN
membrane glass slide (Applied Biosystems). Tissue sections were
dehydrated by successive immersions (30 s. twice) in 70%, 90%
and 100% ethanol solutions. Enzymatic activity was locked by the
immersion in a xylene solution (1 min. Twice) before performing LCM
(Fig. 1C). LCM was performed within 1 h to limit RNA degradation.
The average microdissected area was 5.07 ± 1.42 mm2 (6.01 ±
1.02 mm2 and 4.13 ± 1.13 mm2 for tumor stroma and ﬁbrous tissue
in the adjacent non-tumor tissue, respectively) (Fig. 1D-E). Total RNA
from laser capture microdissected tissues (Fig. 1E) was extracted and
puriﬁed using an Arcturus Picopure RNA isolation kit according to the
manufacturer's instructions (Applied Biosystems, Carlsbad, CA). RNA
was qualiﬁed using a Nanodrop 2000 spectrophotometer (Thermo
Fischer Scientiﬁc, Waltham, MA). The average RNA concentration was
6.18 ± 3.05 ng/μL and the 260/280 ratio was above 2.
2.4. Gene expression analysis
Genome-wide expression proﬁling was performed using a low-
input QuickAmp labeling kit and human SurePrint G3 8x60K
pangenomic microarrays (Agilent Technologies, Santa Clara, CA) as
previously described [2]. Total RNA, in presence of an external
spike-in RNAmixture, were ampliﬁed and labeled with Cy3 ﬂuorescent
dye using Agilent one color low-input QuickAmp labeling kit following
the manufacturer's instructions. Starting from 50 ng total RNA puriﬁed
from LCM tissue samples, ampliﬁcation yieldwas 1.8±0.7 μg cRNA and
speciﬁc activity was 5.8 ± 3.4 pmol Cy3 per μg cRNA.
The same amount of Cy3-labeled cRNA (600 ng) was fragmented at
60 °C for 30 min in a reaction volume of 25 μl containing 1× Agilent
fragmentation buffer and 2× Agilent blocking agent following the
manufacturer's instructions. Following the fragmentation reaction,
25 μ of 2× Agilent hybridization buffer (HI-RPM) was added to the
fragmentation mixture. Forty μL of the mixture were hybridized to
Agilent SurePrint G3 Human GE 8x60K for 17 h at 65 °C in a rotating
Agilent hybridization oven. After hybridization, microarrays were
washed 1 min at room temperature with GE Wash Buffer 1 (Agilent)
and 1 min with GE Wash buffer 2 at 37 °C (Agilent).
Microarray were scanned immediately after washing with the
Agilent DNA Microarray C Scanner (G2565) using one color scanFig. 3. Boxplot of intensity values in each of the 20 msetting for 8x60k array slides. The scanned images were analyzed
with Feature Extraction Software 10.7.3.1 (Agilent Technologies)
using default parameters (protocol GE1_107_Sep09_ssSurrogates
and Grid: 028004_D_F_20101102). Quality control showed a broad
distribution of background subtracted signals, suggesting that RNA
with various abundances (from low to high) could be analyzed
from the genomic dataset (Fig. 2A). The analysis also demonstratedicroarray samples after quantile normalization.
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nal intensity (Fig. 2B). The use of Agilent spike-In RNA demonstrated
a linear relation between signal intensity and the relative abundance
or concentration of the RNA (Fig. 2C). All 20 microarrays from the
genomic dataset were qualiﬁed and further analyzed using GeneSpring
software (Agilent Technologies).
Microarray data were ﬁrst normalized by using the quantile
normalization algorithm. As shown in Fig. 3 this normalization
method corrected putative technical variations between samples.
Without initial gene ﬁltration, Principal Component Analysis (PCA)
using expression values of all genes in all 20 samples mostly separat-
ed tumor from non-tumor samples (Fig. 4). Then, a ﬁltration by “ﬂag”
and “signal intensity” was applied. Were retained only the entities
in which at least 50% of the values in any of the two conditions
(Non Tumoral vs. Tumoral) had a “detected ﬂag” (i.e. a positive and
signiﬁcant feature as deﬁned by GeneSpring). For the ﬁltration
by signal intensity, were retained the entities in which at least 50%
of the values in any of the two conditions (non tumoral, NT vs.
tumoral, T) were within the range of interest (i.e. 20–100th percentile).
Differentially expressed genes were identiﬁed by a two-sample
univariate t-test and a random variance model as described [1].
Permutation P-values for signiﬁcant genes were computed based
on 10,000 random permutations.In conclusion, our genomic dataset is relevant to provide insights on
the molecular pathways altered in the microenvironment of ICC and to
identify novel ICC biomarkers [1,3].
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